Chesapeake Urology is a clinical research site located in Baltimore, Maryland, United States 21237.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
Chesapeake Urology has participated in 6 clinical trials with 3 currently active.
Therapeutic areas: Benign Prostatic Hyperplasia, Urothelial Carcinoma, Urothelial Carcinoma Recurrent.
Sponsors: NeoTract, Inc., UroGen Pharma Ltd., Francis Medical Inc..
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Chesapeake Urology has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Chesapeake Urology has 6 clinical trials on record, with 3 currently active. Their work covers Benign Prostatic Hyperplasia, Urothelial Carcinoma, Urothelial Carcinoma Recurrent.
Yes — Chesapeake Urology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.